What You Should Know:
– Cognizant and Yseop, a leading AI software company, have joined forces to accelerate and streamline scientific content creation in the biopharmaceutical industry.
– The strategic partnership leverages Yseop Copilot, a generative…
Continue Reading
OMNY Health, which helps hospitals monetize operational data, has launched an AI-powered platform for health technology companies to leverage its data on over 75 million patients. The first two companies to utilize the data are…
Continue Reading
MedCity’s annual INVEST Digital Health conference, scheduled for September 18 in Dallas, will delve into innovation at the intersection of AI and drug development, investment trends, consumer-focused diagnostics and validating digital health tools.
This will…
Continue Reading
Raman Parthasarathy, Business Unit Head, Fusemachines
Of the many industries witnessing AI-led transformation, healthcare happens to be one. Today, AI’s promise in healthcare extends beyond automation-led operational and administrative efficiencies. It’s beginning to show a…
Continue Reading
What You Should Know:
– Weave Bio, an AI-native life sciences platform company, announced today the public release of its flagship offering, AutoIND, and $10 million in seed funding co-led by Innovation Endeavors and Magnetic…
Continue Reading
What You Should Know:
– Medable Inc., a leader in modern clinical trial technology, has announced a groundbreaking partnership with Masimo (NASDAQ: MASI) to integrate medical-grade wearable devices into clinical research. This collaboration aims to…
Continue Reading
What You Should Know:
– Sanofi, a global pharmaceutical leader, Formation Bio, an AI-powered drug developer, and OpenAI, a leading research and development company in artificial intelligence, have announced a groundbreaking collaboration. The first-of-its-kind partnership…
Continue Reading
Digital health technologies (DHTs) have the potential to modernize drug development and clinical trial operations by remotely, passively, and continuously collecting ecologically valid evidence that is meaningful to patients’ lived experiences. Such evidence holds…
Continue Reading
What You Should Know:
– Accenture Ventures, the venture capital arm of Accenture, has announced a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development.
– The investment aims…
Continue Reading
The rise of AI-powered health tech for managing administrative tasks to identifying targets for drug development, the push towards value-based care adoption, the adoption of telehealth to facilitate access to care, have helped drive…
Continue Reading
